Cwm LLC decreased its position in shares of Cabot Corporation (NYSE:CBT – Free Report) by 93.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 2,835 shares of the specialty chemicals company’s stock after selling 39,555 shares during the quarter. Cwm LLC’s holdings in Cabot were worth $188,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. NewEdge Advisors LLC lifted its holdings in shares of Cabot by 2,559.5% in the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after buying an additional 947 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Cabot by 32.5% in the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after buying an additional 108,645 shares in the last quarter. Empowered Funds LLC lifted its holdings in shares of Cabot by 102.6% in the first quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock worth $2,341,000 after buying an additional 14,260 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Cabot by 3.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock worth $10,145,000 after buying an additional 4,048 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its holdings in shares of Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares in the last quarter. Institutional investors own 93.18% of the company’s stock.
Trending Headlines about Cabot
Here are the key news stories impacting Cabot this week:
- Positive Sentiment: Q2 adjusted EPS beat consensus — Cabot reported adjusted EPS of $1.61 vs. the Zacks/Street consensus of $1.47, giving the market a clear earnings beat despite tougher year‑ago comparisons. Cabot (CBT) Surpasses Q2 Earnings Estimates
- Positive Sentiment: Dividend increased — the Board raised the quarterly dividend 5% to $0.4725 (annualized $1.89), supporting income investors and signaling confidence in cash flow. Cabot Corporation Board Increases Dividend
- Positive Sentiment: Battery materials and segment performance — Management highlighted battery materials momentum and reported solid segment EBIT (Reinforcement Materials $93M; Performance Chemicals $59M), indicating growth exposure to EV/BESS demand. This helps offset softness in other end markets. Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results
- Neutral Sentiment: FY‑2026 guidance largely in line with Street — Cabot set EPS guidance at $6.00–$6.50 for FY‑2026 (consensus ~$6.24), leaving room for upside or downside within the range; the midpoint is essentially in line with expectations. Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results
- Negative Sentiment: Revenue and year‑over‑year EPS declined — Q2 net sales fell ~3.4% y/y and GAAP EPS (and adjusted EPS) were below last year’s levels, underscoring demand softness in parts of the portfolio that could pressure margins if trends persist. Cabot Q2 Press Release (PDF)
- Negative Sentiment: Planned plant closures / asset optimization — Cabot disclosed intent to pursue manufacturing closures in South America and Europe (subject to consultation), a cost‑cutting move that could trigger restructuring charges, transitional costs or supply risks. Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results
Wall Street Analysts Forecast Growth
View Our Latest Analysis on Cabot
Cabot Trading Up 4.1%
Shares of CBT opened at $78.97 on Wednesday. The company’s fifty day moving average is $73.67 and its 200 day moving average is $70.26. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $83.71. The stock has a market capitalization of $4.12 billion, a PE ratio of 13.83, a P/E/G ratio of 10.00 and a beta of 0.78. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.09 and a current ratio of 1.67.
Cabot (NYSE:CBT – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.47 by $0.14. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The company had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.31 million. During the same quarter in the previous year, the business posted $1.90 earnings per share. Cabot’s quarterly revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Sell-side analysts expect that Cabot Corporation will post 6.27 earnings per share for the current fiscal year.
Cabot Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 29th will be given a $0.4725 dividend. This is a boost from Cabot’s previous quarterly dividend of $0.45. This represents a $1.89 annualized dividend and a yield of 2.4%. The ex-dividend date is Friday, May 29th. Cabot’s dividend payout ratio (DPR) is presently 31.52%.
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Featured Stories
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
